Innate Immunity

Products Related to Innate Immunity(566)

GC52343 113-O12B
CAS: 2803699-72-9
Purity: >98.00%
An ionizable cationic lipidoid
GC52346 IDR 1002 (trifluoroacetate salt)
Purity: >95.00%
A synthetic cationic innate defense regulator peptide
GC52363 Citrullinated Histone H3 (R2 + R8 + R17) (2-22)-biotin Peptide
A biotinylated and citrullinated histone H3 peptide
GC52364 Vimentin (139-159)-biotin Peptide
Purity: >98.00%
A biotinylated vimentin peptide
GC52367 Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide
Purity: >99.00%
A biotinylated and citrullinated mutant vimentin peptide
GC52370 Citrullinated Vimentin (R144) (139-159)-biotin Peptide
Purity: >98.00%
A biotinylated and citrullinated vimentin peptide
GC52371 Vimentin (G146R) (139-159)-biotin Peptide
Purity: >98.00%
A biotinylated mutant vimentin peptide
GC52384 NFAT Inhibitor (cell-permeable) (trifluoroacetate salt)
Purity: >95.00%
A cell-permeable form of NFAT inhibitor
GC52394 LC10
Purity: >98.00%
A lipidoid derivative of lithocholic acid
GC52406 AMPR-22 (trifluoroacetate salt)
Purity: >95.00%
An antimicrobial peptide
GC52412 TT-232 (trifluoroacetate salt)
Purity: >98.00%
A synthetic peptide derivative of somatostatin
GC52424 Bradykinin Fragment (1-5) (trifluoroacetate salt)
Purity: >98.00%
A metabolite of bradykinin
GC52457 WRW4 (trifluoroacetate salt)
Purity: >98.00%
WRW4 (trifluoroacetate salt) is a selective antagonist of formyl peptide receptor 2 (FPR2, formerly known as FPRL1), which is a synthetic C-terminal amidated hexapeptide, its IC 50 value for inhibiting the binding of WKYMVm to FPRL2 is 0.23 μM.
GC52496 Sulfatide (bovine) (sodium salt)
Purity: >95.00%
A mixture of isolated bovine sulfatides
GC52499 Abz-Ala-Pro-Glu-Glu-Ile-Met-Arg-Arg-Gln-EDDnp (trifluoroacetate salt)
Purity: >95.00%
A sensitive substrate for neutrophil elastase
GC52505 Ganglioside GT1b (bovine) (sodium salt)
Purity: >98.00%
A sphingolipid
GC52516 Erbstatin
CAS: 100827-28-9
Purity: >90.00%
A tyrosine kinase inhibitor
GC56074 DSG-PEG 2000
CAS: 308805-39-2
Purity: >99.00%
GC60183 GSK2245035
CAS: 1207629-49-9
Purity: >99.50%
GSK2245035 ist ein hochwirksamer und selektiver intranasaler Agonist des Toll-Like-Rezeptors 7 (TLR7) mit bevorzugten Typ-1-Interferon (IFN)-stimulierenden Eigenschaften.
GC60622 BAY 2416964
CAS: 2242464-44-2
Purity: >98.00%
BAY 2416964 ist ein potenter und oral aktiver Arylhydrocarbonrezeptor (AHR)-Antagonist, extrahiert aus Patent WO2018146010A1, Beispiel 192, hat einen IC50 von 341 nM. BAY 2416964 hat das Potenzial zur Behandlung solider Tumore.
GC61286 SP-8356
CAS: 1454885-45-0
Purity: >99.00%
GC61293 SR-717
CAS: 2375421-09-1
Purity: >99.50%
SR-717 ist ein stabiles Mimetikum des zyklischen Guanosinmonophosphat-Adenosinmonophosphats(cGAMP) mit Antitumor-Aktivität.
GC61367 VAF347
CAS: 574759-62-9
Purity: >99.50%
VAF347 ist ein zellgÄngiger und hochaffiner Arylkohlenwasserstoffrezeptor (AhR)-Agonist und induziert die AhR-Signalgebung.
GC61843 Mofezolac
CAS: 78967-07-4
Purity: >98.50%
Mofezolac, ein nichtsteroidales Antirheumatikum (NSAID), ist ein selektiver, reversibler und oral aktiver COX-1-Hemmer mit einem IC50 von 1,44 nM.

Category Product List
Catalog No.	Product Name	CAS No.	Purity
GC52343	113-O12B	2803699-72-9	>98.00%
GC52343	An ionizable cationic lipidoid
GC52346	IDR 1002 (trifluoroacetate salt)	-	>95.00%
GC52346	A synthetic cationic innate defense regulator peptide
GC52363	Citrullinated Histone H3 (R2 + R8 + R17) (2-22)-biotin Peptide	-	-
GC52363	A biotinylated and citrullinated histone H3 peptide
GC52364	Vimentin (139-159)-biotin Peptide	-	>98.00%
GC52364	A biotinylated vimentin peptide
GC52367	Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide	-	>99.00%
GC52367	A biotinylated and citrullinated mutant vimentin peptide
GC52370	Citrullinated Vimentin (R144) (139-159)-biotin Peptide	-	>98.00%
GC52370	A biotinylated and citrullinated vimentin peptide
GC52371	Vimentin (G146R) (139-159)-biotin Peptide	-	>98.00%
GC52371	A biotinylated mutant vimentin peptide
GC52384	NFAT Inhibitor (cell-permeable) (trifluoroacetate salt)	-	>95.00%
GC52384	A cell-permeable form of NFAT inhibitor
GC52394	LC10	-	>98.00%
GC52394	A lipidoid derivative of lithocholic acid
GC52406	AMPR-22 (trifluoroacetate salt)	-	>95.00%
GC52406	An antimicrobial peptide
GC52412	TT-232 (trifluoroacetate salt)	-	>98.00%
GC52412	A synthetic peptide derivative of somatostatin
GC52424	Bradykinin Fragment (1-5) (trifluoroacetate salt)	-	>98.00%
GC52424	A metabolite of bradykinin
GC52457	WRW4 (trifluoroacetate salt)	-	>98.00%
GC52457	WRW4 (trifluoroacetate salt) is a selective antagonist of formyl peptide receptor 2 (FPR2, formerly known as FPRL1), which is a synthetic C-terminal amidated hexapeptide, its IC 50 value for inhibiting the binding of WKYMVm to FPRL2 is 0.23 μM.
GC52496	Sulfatide (bovine) (sodium salt)	-	>95.00%
GC52496	A mixture of isolated bovine sulfatides
GC52499	Abz-Ala-Pro-Glu-Glu-Ile-Met-Arg-Arg-Gln-EDDnp (trifluoroacetate salt)	-	>95.00%
GC52499	A sensitive substrate for neutrophil elastase
GC52505	Ganglioside GT1b (bovine) (sodium salt)	-	>98.00%
GC52505	A sphingolipid
GC52516	Erbstatin	100827-28-9	>90.00%
GC52516	A tyrosine kinase inhibitor
GC56074	DSG-PEG 2000	308805-39-2	>99.00%
GC60183	GSK2245035	1207629-49-9	>99.50%
GC60183	GSK2245035 ist ein hochwirksamer und selektiver intranasaler Agonist des Toll-Like-Rezeptors 7 (TLR7) mit bevorzugten Typ-1-Interferon (IFN)-stimulierenden Eigenschaften.
GC60622	BAY 2416964	2242464-44-2	>98.00%
GC60622	BAY 2416964 ist ein potenter und oral aktiver Arylhydrocarbonrezeptor (AHR)-Antagonist, extrahiert aus Patent WO2018146010A1, Beispiel 192, hat einen IC50 von 341 nM. BAY 2416964 hat das Potenzial zur Behandlung solider Tumore.
GC61286	SP-8356	1454885-45-0	>99.00%
GC61293	SR-717	2375421-09-1	>99.50%
GC61293	SR-717 ist ein stabiles Mimetikum des zyklischen Guanosinmonophosphat-Adenosinmonophosphats(cGAMP) mit Antitumor-Aktivität.
GC61367	VAF347	574759-62-9	>99.50%
GC61367	VAF347 ist ein zellgÄngiger und hochaffiner Arylkohlenwasserstoffrezeptor (AhR)-Agonist und induziert die AhR-Signalgebung.
GC61843	Mofezolac	78967-07-4	>98.50%
GC61843	Mofezolac, ein nichtsteroidales Antirheumatikum (NSAID), ist ein selektiver, reversibler und oral aktiver COX-1-Hemmer mit einem IC50 von 1,44 nM.